HC
Therapeutic Areas
HCW Biologics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Fusion Immunotherapeutic | Autoimmune Disease | Phase 1 |
| Commercial-ready Fusion Compounds | Reagents for cell-based therapies (Cancer, Infectious Diseases) | Commercial |
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Fusion Immunotherapeutic | Autoimmune Disease | Phase 1 |
| Commercial-ready Fusion Compounds | Reagents for cell-based therapies (Cancer, Infectious Diseases) | Commercial |